Development and validation of Ran as a prognostic marker in stage I and stage II primary breast cancer.
El-Tanani M, Platt-Higgins A, Nsairat H, Matalka II, Ahmed KA, Zhang SD, Alshaer W, Awidi A, Matchett KB, Aljabali AA, et al. Life Sci. 2023 Sep 15; 329:121964. Epub 2023 Jul 18.